Moreover, the ratios of CD8+ T cells to CD11b+ cells were significantly increased in the RGD + aPD-1 group because of the accumulation of cytotoxic T cells, indicating antitumor immune responses in the glioma TME. This evidence concerns the gene CD8A and central nervous system cancer.